Acute Hepatitis C as an Acute Cause of Acute-on-chronic Liver Failure in Alcohol-associated Liver Disease.
作者信息
Choudhary Narendra S, Singh Kunwar A, Dhampalwar Swapnil, Saraf Neeraj, Singh Virendra
机构信息
Institute of Liver Transplantation and Regenerative Medicine, Medanta: The Medicity, Gurugram, Haryana, India.
Director, Punjab Institute of Liver and Biliary Sciences, Mohali, Punjab, India.
出版信息
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102423. doi: 10.1016/j.jceh.2024.102423. Epub 2024 Oct 10.
Abstract
摘要
相似文献
1
Acute Hepatitis C as an Acute Cause of Acute-on-chronic Liver Failure in Alcohol-associated Liver Disease.
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102423. doi: 10.1016/j.jceh.2024.102423. Epub 2024 Oct 10.
2
NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements. 2002;19(3):1-46.
3
[Predictive value of liver-to-spleen volume ratio for short-term prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure].
Zhonghua Yi Xue Za Zhi. 2025 Jun 24;105(24):1989-1996. doi: 10.3760/cma.j.cn112137-20250222-00424.
4
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD011645. doi: 10.1002/14651858.CD011645.pub2.
5
Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.
Cochrane Database Syst Rev. 2017 Mar 13;3(3):CD011644. doi: 10.1002/14651858.CD011644.pub2.
6
Direct-acting antivirals for chronic hepatitis C.
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.
7
Vitamin D supplementation for chronic liver diseases in adults.
Cochrane Database Syst Rev. 2017 Nov 3;11(11):CD011564. doi: 10.1002/14651858.CD011564.pub2.
8
Direct-acting antivirals for chronic hepatitis C.
Cochrane Database Syst Rev. 2017 Jun 6;6(6):CD012143. doi: 10.1002/14651858.CD012143.pub2.
9
Cryopreserved cGMP-compliant human pluripotent stem cell-derived hepatic progenitors rescue mice from acute liver failure through rapid paracrine effects on liver cells.
Stem Cell Res Ther. 2024 Mar 12;15(1):71. doi: 10.1186/s13287-024-03673-9.
10
Construction and validation of HBV-ACLF bacterial infection diagnosis model based on machine learning.
BMC Infect Dis. 2025 Jul 1;25(1):847. doi: 10.1186/s12879-025-11199-5.
本文引用的文献
1
Managing HBV and HCV Infection Pre- and Post-liver Transplant.
J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101287. doi: 10.1016/j.jceh.2023.09.008. Epub 2023 Sep 23.
2
Acute hepatitis C virus infection: clinical update and remaining challenges.
Clin Mol Hepatol. 2023 Jul;29(3):623-642. doi: 10.3350/cmh.2022.0349. Epub 2023 Feb 20.
3
Corrigendum to 'EASL recommendations on treatment of hepatitis C: Final update of the series [J Hepatol 73 (2020) 1170-1218].
J Hepatol. 2023 Feb;78(2):452. doi: 10.1016/j.jhep.2022.10.006. Epub 2022 Dec 1.
4
Liver Transplantation for Acute on Chronic Liver Failure.
J Clin Exp Hepatol. 2017 Sep;7(3):247-252. doi: 10.1016/j.jceh.2017.08.001. Epub 2017 Aug 24.
5
Potential Liver Transplant Recipients with Hepatitis C: Should They Be Treated Before or After Transplantation?
J Clin Exp Hepatol. 2017 Mar;7(1):42-54. doi: 10.1016/j.jceh.2017.01.116. Epub 2017 Feb 6.
6
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.
Gastroenterology. 2016 Apr;150(4):785-90. doi: 10.1053/j.gastro.2016.02.042. Epub 2016 Feb 24.
7
Acute hepatitis C: current status and remaining challenges.
J Hepatol. 2008 Oct;49(4):625-33. doi: 10.1016/j.jhep.2008.07.005. Epub 2008 Jul 17.
Zotero 插件